Radiation Therapy

prostate cancer, radiation therapy, high-dose-rate brachytherapy, HDR, Red Journal study

This is a single-fraction high-dose-rate prostate implant imaging and dosimetry. Image courtesy of Daniel Krauss/American Society for Radiation Oncology (ASTRO)

News | Brachytherapy Systems | March 06, 2017

March 6, 2017 — Results from a new prospective clinical trial indicate high-dose-rate (HDR)...

brain metastases, cancer, survey, UCLA, Dr. Percy Lee, whole brain radiotherapy, stereotactic radiosurgery

Image of a human brain with seven metastases, depicted here as the small colored spheres inside rectangles. Image courtesy of UCLA Jonsson Comprehensive Cancer Center.

News | Radiation Therapy | March 03, 2017

March 3, 2017 — An extensive study by University of California Los Angeles (UCLA) researchers found significant...

brain FUS

Brain FUS uses an array of about 1,000 elements designed to overcome attenuation issues presented by the skull and to diffuse the heating over a large area of the brain to prevent damaging healthly tissue. 

Feature | Radiation Oncology | March 02, 2017 | By Dave Fornell

Focused ultrasound (FUS), also called high-...

Accuray, cancer patient websites, CyberKnife, TomoTherapy, radiation therapy, radiotherapy, RT
News | Radiation Therapy | March 02, 2017

March 2, 2017 — The Internet is one of the first places patients turn to for healthcare information after receiving...

ViewRay, MRIdian Linac system, FDA 510k approval, MRI-guided radiation therapy
Technology | Image Guided Radiation Therapy (IGRT) | February 27, 2017

February 27, 2017 — ViewRay Inc. announced that the company received 510(k) clearance from the U.S. Food and Drug...

Accuray, CyberKnife system, SBRT, long-term disease control, prostate cancer, ASCO GU study
News | Radiation Therapy | February 17, 2017

February 17, 2017 — Accuray Inc. recently announced data from a prospective, Phase II, 17-center study which showed...

targeted radiosurgery, stereotactic radiosurgery, whole-brain radiation, brain tumor metastases, Cureus, University of Missouri School of Medicine study
News | Radiation Therapy | February 16, 2017

February 16, 2017 — University of Missouri (MU) School of Medicine researchers compared two common postsurgical...

ASTRO guideline, bone metastases, pallliative radiation therapy, gold standard
News | Radiation Therapy | February 14, 2017

February 14, 2017 — The American Society for Radiation Oncology (ASTRO) recently published an updated clinical...

Accuray, Radixact treatment delivery system, TomoTherapy, Shonin approval, Japan
News | Radiation Therapy | February 13, 2017

February 13, 2017 — Accuray Inc. announced that it has received Shonin approval from the Japanese Ministry of Health...

state of the proton therapy market entering 2017, proton therapy, radiation therapy, Robust Insight survey
News | Proton Therapy | February 10, 2017

February 10, 2017 — Independent market research consultancy Robust Insight recently conveyed a survey commissioned...

EGFR mutant lung cancer, brain metastases, order of treatment, radiation therapy, EGFR-directed drugs, Journal of Clinical Oncology study
News | Lung Cancer | February 09, 2017

February 9, 2017 — A study published in the...

IBA, Dolphin Online Ready Patient QA and Monitoring solution, radiotherapy, North West Cancer Centre, Londonderry, Northern Ireland, first in U.K.
News | Radiation Therapy | February 07, 2017

February 7, 2017 — IBA (Ion Beam Applications S.A.) recently announced the first clinical implementation of its...

Institut Curie, Onxeo, radiotherapy, immunotherapy, DNA repair inhibitors, AsiDNA, DBait
News | Radiation Therapy | February 06, 2017

February 6, 2017 — Onxeo S.A. and the Institut Curie launched a series of studies on World Cancer Day (Feb. 4) aimed...

radiotargeted therapy, SST2 antagonists, combat cancer, neuroendocrine tumors, NETs, Journal of Nuclear Medicine study

Comparative receptor autoradiography in various cancer types (A = HE staining) with I-125-JR11 (B+C) and I-125-Tyr3-octreotide (D+E). B and D are the respective total binding, C and E the respective non-specific binding. Bars = 1 mm.

I: Breast cancer. II: Renal cell cancer. III: Medullary thyroid cancer. IV: Non-Hodgkin lymphoma. V: Colon cancer. In cancers I-V, the sections were incubated with 30’000 cpm/100 μl of antagonist or agonist. Cancers I-IV show a much higher density of sst2 with the antagonist. The colon cancer V is negative. VI: Ileal NET, incubated with 10’000 cpm/100 μl of antagonist or agonist. Credit: Jean Claude Reubi, Institute of Pathology, University of Berne, Berne, Switzerland. 

News | Radiation Therapy | February 06, 2017

February 6, 2017 — A study published in the February issue of...

recurrent prostate cancer, hormone therapy, radiation therapy, Cedars-Sinai study, New England Journal of Medicine
News | Prostate Cancer | February 03, 2017

February 3, 2017 — Adding hormonal therapy to radiation treatment can significantly improve the average long-term...

ASTRO, lawmakers, healthcare access, insurance coverage, Congress, radiation therapy
News | Radiation Therapy | February 03, 2017

February 3, 2017 — As the new Congress and administration wrestle with policy decisions on the provision of high-...

insightec exablate high intensity focused ultrasound system

The InSightec ExAblate focused ultrasound system developed to treat essential tremor. Studies are underway to see if FUS can be used to treat other brain conditions and brain cancer.

Feature | Focused Ultrasound Therapy | February 03, 2017 | Dave Fornell

Focused ultrasound (FUS), also called...

RayStation 6, new release, RaySearch Laboratories, radiation therapy, treatment planning, TomoTherapy
Technology | Treatment Planning | February 01, 2017

February 1, 2017 — RayStation 6, the latest release of RaySearch’s...

RayStation, radiation therapy, treatment planning system, University of Wisconsin Madison
News | Treatment Planning | January 30, 2017

January 30, 2017 — The Department of Human Oncology at the University of Wisconsin-Madison has chosen RayStation as...

Overlay Init